Evolent Health, Inc. insider trading

EVHNYSE

$3.46+0.07 (+2.06%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-56.1%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
Date	Category	Person	Role	Action	Amount	Change in holding

Open market purchase

Open market sell

Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium

Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Unlock quarterly net flow

Key players

SBSeth BlackleyChief Executive Officer1.5169%of company
DJDaniel Joseph McCarthyPRESIDENT0.7808%of company
MRMario RamosChief Financial Officer0.7002%of company
JPJohn Paul JohnsonChief Financial Officer0.3686%of company
JWJonathan WeinbergGeneral Counsel0.3396%of company
EAEmily Ann RaffertyChief Operating Officer0.1551%of company
PJPeter J. GruaDirector0.1475%of company
RMRichard M. JelinekDirector0.1282%of company
KKKim KeckDirector0.1223%of company
BBBrendan B. SpringstubbDirector0.1191%of company

AI Activity Analysis

Premium

Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto

Company	Insider / role	Action	ΔOwn	Avg price	Amount
EVH	Daniel Joseph McCarthyPRESIDENT	Open market sell$329K	-9.1%	$5.00	$329K	Aug 26, 2026	Aug 28, 2026
EVH	Brendan B. SpringstubbDirector	Open market purchase$38.2K	+20.5%	$3.82	$38.2K	Nov 18, 2025	Nov 19, 2025

End of history · 2 transactions